GRIN Therapeutics
New York
About GRIN Therapeutics
GRIN Therapeutics is a clinical-stage biotechnology company dedicated to developing precision therapeutics for serious pediatric neurodevelopmental disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $140.0M
- Funding stage: Late Stage Venture
- Last round: Series D (May 2025)
- Website: grintherapeutics.com
- Phone: +1-877-225-0014
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/grin-therapeutics-59465 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.